Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Survival after complete surgical resection of multiple metastases from renal cell carcinoma - Alt - 2011 - Cancer - Wiley Online Library
Overall survival of 124 patients who initially received cytokines... | Download Scientific Diagram
Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer – Consult QD
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
EAU 2021: Evolving Landscape of First-Line Systemic Treatment in Metastatic Renal Cell Carcinoma
Overall survival rates of 95 patients with metastatic renal cell... | Download Scientific Diagram
Overall survival in metastatic renal cell carcinoma patients after... | Download Scientific Diagram
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
Duration of First-line Treatment with Molecular Targeted-Therapy Is a Prognostic Factor in Metastatic Renal Cell Carcinoma | Anticancer Research
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
xmlinkhub
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program | Journal for ImmunoTherapy of Cancer
Frontiers | Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
JCM | Free Full-Text | Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Thumbnails — IMDC | International mRCC Database Consortium
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
